Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Sickle SCAN™ (BioMedomics) fulfills analytical conditions for neonatal screening of sickle cell disease.

Nguyen-Khoa T, Mine L, Allaf B, Ribeil JA, Remus C, Stanislas A, Gauthereau V, Enouz S, Kim JS, Yang X, Gluckman E, Beaudeux JL, Munnich A, Girot R, Cavazzana M.

Ann Biol Clin (Paris). 2018 Aug 1;76(4):416-420. doi: 10.1684/abc.2018.1354.

PMID:
29976532
2.

Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia.

Thompson AA, Walters MC, Kwiatkowski J, Rasko JEJ, Ribeil JA, Hongeng S, Magrin E, Schiller GJ, Payen E, Semeraro M, Moshous D, Lefrere F, Puy H, Bourget P, Magnani A, Caccavelli L, Diana JS, Suarez F, Monpoux F, Brousse V, Poirot C, Brouzes C, Meritet JF, Pondarré C, Beuzard Y, Chrétien S, Lefebvre T, Teachey DT, Anurathapan U, Ho PJ, von Kalle C, Kletzel M, Vichinsky E, Soni S, Veres G, Negre O, Ross RW, Davidson D, Petrusich A, Sandler L, Asmal M, Hermine O, De Montalembert M, Hacein-Bey-Abina S, Blanche S, Leboulch P, Cavazzana M.

N Engl J Med. 2018 Apr 19;378(16):1479-1493. doi: 10.1056/NEJMoa1705342.

PMID:
29669226
3.

Transfusion-related adverse events are decreased in pregnant women with sickle cell disease by a change in policy from systematic transfusion to prophylactic oxygen therapy at home: A retrospective survey by the international sickle cell disease observatory.

Ribeil JA, Labopin M, Stanislas A, Deloison B, Lemercier D, Habibi A, Albinni S, Charlier C, Lortholary O, Lefrere F, De Montalembert M, Blanche S, Galactéros F, Tréluyer JM, Gluckman E, Ville Y, Joseph L, Delville M, Benachi A, Cavazzana M.

Am J Hematol. 2018 Jun;93(6):794-802. doi: 10.1002/ajh.25097. Epub 2018 Apr 17.

4.

Plerixafor enables safe, rapid, efficient mobilization of hematopoietic stem cells in sickle cell disease patients after exchange transfusion.

Lagresle-Peyrou C, Lefrère F, Magrin E, Ribeil JA, Romano O, Weber L, Magnani A, Sadek H, Plantier C, Gabrion A, Ternaux B, Félix T, Couzin C, Stanislas A, Tréluyer JM, Lamhaut L, Joseph L, Delville M, Miccio A, André-Schmutz I, Cavazzana M.

Haematologica. 2018 May;103(5):778-786. doi: 10.3324/haematol.2017.184788. Epub 2018 Feb 22.

5.

High bone mineral density in sickle cell disease: Prevalence and characteristics.

De Luna G, Ranque B, Courbebaisse M, Ribeil JA, Khimoud D, Dupeux S, Silvera J, Offredo L, Pouchot J, Arlet JB.

Bone. 2018 May;110:199-203. doi: 10.1016/j.bone.2018.02.003. Epub 2018 Feb 8.

PMID:
29428552
6.

Indications and outcome of splenectomy in hematologic disease.

Bonnet S, Guédon A, Ribeil JA, Suarez F, Tamburini J, Gaujoux S.

J Visc Surg. 2017 Dec;154(6):421-429. doi: 10.1016/j.jviscsurg.2017.06.011. Epub 2017 Jul 27.

PMID:
28757383
7.

Roles of APOL1 G1 and G2 variants in sickle cell disease patients: kidney is the main target.

Kormann R, Jannot AS, Narjoz C, Ribeil JA, Manceau S, Delville M, Joste V, Prié D, Pouchot J, Thervet E, Courbebaisse M, Arlet JB.

Br J Haematol. 2017 Oct;179(2):323-335. doi: 10.1111/bjh.14842. Epub 2017 Jul 12.

PMID:
28699644
8.

[Gene therapy for sickle cell disease].

Ribeil JA, Blanche S, Cavazzana M.

Med Sci (Paris). 2017 May;33(5):463-465. doi: 10.1051/medsci/20173305002. Epub 2017 Jun 14. French. No abstract available.

9.

Cardiac iron overload in chronically transfused patients with thalassemia, sickle cell anemia, or myelodysplastic syndrome.

de Montalembert M, Ribeil JA, Brousse V, Guerci-Bresler A, Stamatoullas A, Vannier JP, Dumesnil C, Lahary A, Touati M, Bouabdallah K, Cavazzana M, Chauzit E, Baptiste A, Lefebvre T, Puy H, Elie C, Karim Z, Ernst O, Rose C.

PLoS One. 2017 Mar 3;12(3):e0172147. doi: 10.1371/journal.pone.0172147. eCollection 2017.

10.

Gene Therapy in a Patient with Sickle Cell Disease.

Ribeil JA, Hacein-Bey-Abina S, Payen E, Magnani A, Semeraro M, Magrin E, Caccavelli L, Neven B, Bourget P, El Nemer W, Bartolucci P, Weber L, Puy H, Meritet JF, Grevent D, Beuzard Y, Chrétien S, Lefebvre T, Ross RW, Negre O, Veres G, Sandler L, Soni S, de Montalembert M, Blanche S, Leboulch P, Cavazzana M.

N Engl J Med. 2017 Mar 2;376(9):848-855. doi: 10.1056/NEJMoa1609677.

11.

Arterio-venous fistula for automated red blood cells exchange in patients with sickle cell disease: Complications and outcomes.

Delville M, Manceau S, Ait Abdallah N, Stolba J, Awad S, Damy T, Gellen B, Sabbah L, Debbache K, Audard V, Beaumont JL, Arnaud C, Chantalat-Auger C, Driss F, Lefrère F, Cavazzana M, Franco G, Galacteros F, Ribeil JA, Gellen-Dautremer J.

Am J Hematol. 2017 Feb;92(2):136-140. doi: 10.1002/ajh.24600. Epub 2016 Dec 7.

12.

Carboxy-terminal fragment of fibroblast growth factor 23 induces heart hypertrophy in sickle cell disease.

Courbebaisse M, Mehel H, Petit-Hoang C, Ribeil JA, Sabbah L, Tuloup-Minguez V, Bergerat D, Arlet JB, Stanislas A, Souberbielle JC, Le Clésiau H, Fischmeister R, Friedlander G, Prié D.

Haematologica. 2017 Feb;102(2):e33-e35. doi: 10.3324/haematol.2016.150987. Epub 2016 Oct 27. No abstract available.

13.

Cytoplasmic proliferating cell nuclear antigen connects glycolysis and cell survival in acute myeloid leukemia.

Ohayon D, De Chiara A, Chapuis N, Candalh C, Mocek J, Ribeil JA, Haddaoui L, Ifrah N, Hermine O, Bouillaud F, Frachet P, Bouscary D, Witko-Sarsat V.

Sci Rep. 2016 Oct 19;6:35561. doi: 10.1038/srep35561.

14.

Gene Therapy with Hematopoietic Stem Cells: The Diseased Bone Marrow's Point of View.

Cavazzana M, Ribeil JA, Lagresle-Peyrou C, André-Schmutz I.

Stem Cells Dev. 2017 Jan 15;26(2):71-76. doi: 10.1089/scd.2016.0230. Epub 2016 Oct 16. Review.

15.

Gene Therapy of the β-Hemoglobinopathies by Lentiviral Transfer of the β(A(T87Q))-Globin Gene.

Negre O, Eggimann AV, Beuzard Y, Ribeil JA, Bourget P, Borwornpinyo S, Hongeng S, Hacein-Bey S, Cavazzana M, Leboulch P, Payen E.

Hum Gene Ther. 2016 Feb;27(2):148-65. doi: 10.1089/hum.2016.007.

16.

Proteinase 3 on apoptotic cells disrupts immune silencing in autoimmune vasculitis.

Millet A, Martin KR, Bonnefoy F, Saas P, Mocek J, Alkan M, Terrier B, Kerstein A, Tamassia N, Satyanarayanan SK, Ariel A, Ribeil JA, Guillevin L, Cassatella MA, Mueller A, Thieblemont N, Lamprecht P, Mouthon L, Perruche S, Witko-Sarsat V.

J Clin Invest. 2015 Nov 2;125(11):4107-21. doi: 10.1172/JCI78182. Epub 2015 Oct 5.

17.

[French guidelines for the management of adult sickle cell disease: 2015 update].

Habibi A, Arlet JB, Stankovic K, Gellen-Dautremer J, Ribeil JA, Bartolucci P, Lionnet F; centre de référence maladies rares « syndromes drépanocytaires majeurs ».

Rev Med Interne. 2015 May 11;36(5 Suppl 1):5S3-84. doi: 10.1016/S0248-8663(15)60002-9. French.

PMID:
26007619
18.

[HSP70 regulates ineffective erythropoiesis in beta-thalassaemia].

Arlet JB, Ribeil JA, Guillem F, Hermine O, Courtois G.

Med Sci (Paris). 2015 Jan;31(1):9-11. doi: 10.1051/medsci/20153101002. Epub 2015 Feb 6. French. No abstract available.

19.

A biomimetic microfluidic chip to study the circulation and mechanical retention of red blood cells in the spleen.

Picot J, Ndour PA, Lefevre SD, El Nemer W, Tawfik H, Galimand J, Da Costa L, Ribeil JA, de Montalembert M, Brousse V, Le Pioufle B, Buffet P, Le Van Kim C, Français O.

Am J Hematol. 2015 Apr;90(4):339-45. doi: 10.1002/ajh.23941. Epub 2015 Feb 2.

20.

HSP70 sequestration by free α-globin promotes ineffective erythropoiesis in β-thalassaemia.

Arlet JB, Ribeil JA, Guillem F, Negre O, Hazoume A, Marcion G, Beuzard Y, Dussiot M, Moura IC, Demarest S, de Beauchêne IC, Belaid-Choucair Z, Sevin M, Maciel TT, Auclair C, Leboulch P, Chretien S, Tchertanov L, Baudin-Creuza V, Seigneuric R, Fontenay M, Garrido C, Hermine O, Courtois G.

Nature. 2014 Oct 9;514(7521):242-6. doi: 10.1038/nature13614. Epub 2014 Aug 24.

PMID:
25156257
21.

An activin receptor IIA ligand trap corrects ineffective erythropoiesis in β-thalassemia.

Dussiot M, Maciel TT, Fricot A, Chartier C, Negre O, Veiga J, Grapton D, Paubelle E, Payen E, Beuzard Y, Leboulch P, Ribeil JA, Arlet JB, Coté F, Courtois G, Ginzburg YZ, Daniel TO, Chopra R, Sung V, Hermine O, Moura IC.

Nat Med. 2014 Apr;20(4):398-407. doi: 10.1038/nm.3468. Epub 2014 Mar 23.

PMID:
24658077
22.

[HSP70, an erythropoiesis regulator that determines the fate of erythroblasts between death and differentiation].

Hermine O, Arlet JB, Ribeil JA, Guillerm F, Vandekerkhove J, Courtois G.

Transfus Clin Biol. 2013 May;20(2):144-7. doi: 10.1016/j.tracli.2013.03.005. Epub 2013 May 2. Review. French.

PMID:
23643330
23.

Ineffective erythropoiesis in β -thalassemia.

Ribeil JA, Arlet JB, Dussiot M, Moura IC, Courtois G, Hermine O.

ScientificWorldJournal. 2013 Mar 28;2013:394295. doi: 10.1155/2013/394295. Print 2013. Review.

24.

Relationship between vitamin D deficiency and bone fragility in sickle cell disease: a cohort study of 56 adults.

Arlet JB, Courbebaisse M, Chatellier G, Eladari D, Souberbielle JC, Friedlander G, de Montalembert M, Prié D, Pouchot J, Ribeil JA.

Bone. 2013 Jan;52(1):206-11. doi: 10.1016/j.bone.2012.10.005. Epub 2012 Oct 13.

PMID:
23072921
25.

Determination of the best method to estimate glomerular filtration rate from serum creatinine in adult patients with sickle cell disease: a prospective observational cohort study.

Arlet JB, Ribeil JA, Chatellier G, Eladari D, De Seigneux S, Souberbielle JC, Friedlander G, de Montalembert M, Pouchot J, Prié D, Courbebaisse M.

BMC Nephrol. 2012 Aug 6;13:83. doi: 10.1186/1471-2369-13-83.

26.

A specific time course for mobilization of peripheral blood CD34+ cells after plerixafor injection in very poor mobilizer patients: impact on the timing of the apheresis procedure.

Lefrère F, Mauge L, Réa D, Ribeil JA, Dal Cortivo L, Brignier AC, Aoun C, Larghéro J, Cavazzana-Calvo M, Micléa JM.

Transfusion. 2013 Mar;53(3):564-9. doi: 10.1111/j.1537-2995.2012.03744.x. Epub 2012 Jun 21.

PMID:
22725259
27.

Extensive chronic GVHD is associated with donor blood CD34+ cell count after G-CSF mobilization in non-myeloablative allogeneic PBSC transplantation.

Dhédin N, Prébet T, De Latour RP, Katsahian S, Kuentz M, Piard N, Réa D, Norol F, Jouet JP, Ribeil JA, Tabrizi R, Rio B, Lioure B, Tiberghien P, Bourhis JH, Sirvent A, Bordigoni P, Blaise D, Michallet M, Vernant JP.

Bone Marrow Transplant. 2012 Dec;47(12):1564-8. doi: 10.1038/bmt.2012.75. Epub 2012 May 21.

PMID:
22609881
28.

Thrombotic microangiopathy and Purtscher-like retinopathy as a rare presentation of juvenile dermatomyositis.

Bader-Meunier B, Monnet D, Barnerias C, Halphen I, Lambot-Juhan K, Chalumeau M, Costedoat-Chalumeau N, Ribeil JA, Bodemer C, Gherardi R.

Pediatrics. 2012 Mar;129(3):e821-4. doi: 10.1542/peds.2011-0338. Epub 2012 Feb 6.

PMID:
22311994
29.

Protective effect of systemic administration of erythropoietin on auditory brain stem response and compound action potential thresholds in an animal model of cochlear implantation.

Quesnel S, Nguyen Y, Campo P, Hermine O, Ribeil JA, Elmaleh M, Grayeli AB, Ferrary E, Sterkers O, Couloigner V.

Ann Otol Rhinol Laryngol. 2011 Nov;120(11):737-47.

PMID:
22224316
30.

Defective nuclear localization of Hsp70 is associated with dyserythropoiesis and GATA-1 cleavage in myelodysplastic syndromes.

Frisan E, Vandekerckhove J, de Thonel A, Pierre-Eugène C, Sternberg A, Arlet JB, Floquet C, Gyan E, Kosmider O, Dreyfus F, Gabet AS, Courtois G, Vyas P, Ribeil JA, Zermati Y, Lacombe C, Mayeux P, Solary E, Garrido C, Hermine O, Fontenay M.

Blood. 2012 Feb 9;119(6):1532-42. doi: 10.1182/blood-2011-03-343475. Epub 2011 Dec 12.

31.

Polymeric IgA1 controls erythroblast proliferation and accelerates erythropoiesis recovery in anemia.

Coulon S, Dussiot M, Grapton D, Maciel TT, Wang PH, Callens C, Tiwari MK, Agarwal S, Fricot A, Vandekerckhove J, Tamouza H, Zermati Y, Ribeil JA, Djedaini K, Oruc Z, Pascal V, Courtois G, Arnulf B, Alyanakian MA, Mayeux P, Leanderson T, Benhamou M, Cogné M, Monteiro RC, Hermine O, Moura IC.

Nat Med. 2011 Oct 23;17(11):1456-65. doi: 10.1038/nm.2462.

PMID:
22019886
32.

[Hyperuricemia in sickle cell disease in France].

Arlet JB, Ribeil JA, Chatellier G, Pouchot J, de Montalembert M, Prié D, Courbebaisse M.

Rev Med Interne. 2012 Jan;33(1):13-7. doi: 10.1016/j.revmed.2011.07.002. Epub 2011 Sep 9. French.

PMID:
21907467
33.

Vitronectin dictates intraglomerular fibrinolysis in immune-mediated glomerulonephritis.

Mesnard L, Rafat C, Vandermeersch S, Hertig A, Cathelin D, Xu-Dubois YC, Jouanneau C, Keller AC, Ribeil JA, Leite-de-Moraes MC, Rondeau E.

FASEB J. 2011 Oct;25(10):3543-53. doi: 10.1096/fj.11-180752. Epub 2011 Jul 15.

PMID:
21764994
34.

Downregulation of basophil-derived IL-4 and in vivo T(H)2 IgE responses by serotonin and other organic cation transporter 3 ligands.

Schneider E, Machavoine F, Bricard-Rignault R, Levasseur M, Petit-Bertron AF, Gautron S, Ribeil JA, Launay JM, Mecheri S, Côté F, Dy M.

J Allergy Clin Immunol. 2011 Oct;128(4):864-871.e2. doi: 10.1016/j.jaci.2011.04.043. Epub 2011 Jun 2.

PMID:
21636115
35.

[Abnormal tongue].

Arlet JB, Pouchot J, Ribeil JA.

Rev Med Interne. 2012 Apr;33(4):227-8. doi: 10.1016/j.revmed.2011.03.009. Epub 2011 Apr 13. French. No abstract available.

PMID:
21492972
36.

First experience of autologous peripheral blood stem cell mobilization with biosimilar granulocyte colony-stimulating factor.

Lefrère F, Brignier AC, Elie C, Ribeil JA, Bernimoulin M, Aoun C, Dal Cortivo L, Delarue R, Hermine O, Cavazzana-Calvo M.

Adv Ther. 2011 Apr;28(4):304-10. doi: 10.1007/s12325-011-0009-1. Epub 2011 Mar 10.

PMID:
21400232
37.

Caspase-activated ROCK-1 allows erythroblast terminal maturation independently of cytokine-induced Rho signaling.

Gabet AS, Coulon S, Fricot A, Vandekerckhove J, Chang Y, Ribeil JA, Lordier L, Zermati Y, Asnafi V, Belaid Z, Debili N, Vainchenker W, Varet B, Hermine O, Courtois G.

Cell Death Differ. 2011 Apr;18(4):678-89. doi: 10.1038/cdd.2010.140. Epub 2010 Nov 12.

38.

Proliferating cell nuclear antigen acts as a cytoplasmic platform controlling human neutrophil survival.

Witko-Sarsat V, Mocek J, Bouayad D, Tamassia N, Ribeil JA, Candalh C, Davezac N, Reuter N, Mouthon L, Hermine O, Pederzoli-Ribeil M, Cassatella MA.

J Exp Med. 2010 Nov 22;207(12):2631-45. doi: 10.1084/jem.20092241. Epub 2010 Oct 25.

39.

HSP27 controls GATA-1 protein level during erythroid cell differentiation.

de Thonel A, Vandekerckhove J, Lanneau D, Selvakumar S, Courtois G, Hazoume A, Brunet M, Maurel S, Hammann A, Ribeil JA, Zermati Y, Gabet AS, Boyes J, Solary E, Hermine O, Garrido C.

Blood. 2010 Jul 8;116(1):85-96. doi: 10.1182/blood-2009-09-241778. Epub 2010 Apr 21.

40.

Targeting iron homeostasis induces cellular differentiation and synergizes with differentiating agents in acute myeloid leukemia.

Callens C, Coulon S, Naudin J, Radford-Weiss I, Boissel N, Raffoux E, Wang PH, Agarwal S, Tamouza H, Paubelle E, Asnafi V, Ribeil JA, Dessen P, Canioni D, Chandesris O, Rubio MT, Beaumont C, Benhamou M, Dombret H, Macintyre E, Monteiro RC, Moura IC, Hermine O.

J Exp Med. 2010 Apr 12;207(4):731-50. doi: 10.1084/jem.20091488. Epub 2010 Apr 5.

41.

[Anemia in adult sickle cell disease].

Arlet JB, Bartolucci P, Habibi A, Ribeil JA, Stankovic K, Lionnet F; GREDA.

Rev Med Interne. 2009 Dec;30 Suppl 4:S319-22. Epub 2009 Oct 15. Review. French. No abstract available.

PMID:
19836111
42.

[Guidelines for management of adult sickle cell disease].

Lionnet F, Arlet JB, Bartolucci P, Habibi A, Ribeil JA, Stankovic K; groupe de recommandations et d'étude de la drépanocytose de l'adulte (GREDA).

Rev Med Interne. 2009 Sep;30 Suppl 3:S162-223. doi: 10.1016/j.revmed.2009.07.001. Epub 2009 Aug 26. French.

PMID:
19713011
43.

Selective reduction of JAK2V617F-dependent cell growth by siRNA/shRNA and its reversal by cytokines.

Jedidi A, Marty C, Oligo C, Jeanson-Leh L, Ribeil JA, Casadevall N, Galy A, Vainchenker W, Villeval JL.

Blood. 2009 Aug 27;114(9):1842-51. doi: 10.1182/blood-2008-09-176875. Epub 2009 Jul 9.

44.

Fanconi syndrome due to deferasirox.

Rafat C, Fakhouri F, Ribeil JA, Delarue R, Le Quintrec M.

Am J Kidney Dis. 2009 Nov;54(5):931-4. doi: 10.1053/j.ajkd.2009.03.013. Epub 2009 Jun 3.

PMID:
19493602
45.

Serum-free culture medium and IL-7 costimulation increase the sensitivity of ELISpot detection.

Martinuzzi E, Scotto M, Enée E, Brezar V, Ribeil JA, van Endert P, Mallone R.

J Immunol Methods. 2008 Apr 20;333(1-2):61-70. doi: 10.1016/j.jim.2008.01.003. Epub 2008 Jan 29.

46.

[Hsp 70, guardian angel of GATA-1 during erythroid differentiation].

Vandekerckhove J, Ribeil JA, Zermati Y, Garrido C, Courtois G, Solary E, Hermine O.

Med Sci (Paris). 2008 Jan;24(1):37-40. doi: 10.1051/medsci/200824137. French. No abstract available.

47.

Evaluation of an algorithm based on peripheral blood hematopoietic progenitor cell and CD34+ cell concentrations to optimize peripheral blood progenitor cell collection by apheresis.

Lefrère F, Zohar S, Beaudier S, Audat F, Ribeil JA, Ghez D, Varet B, Cavazzana-Calvo M, Dal Cortivo L, Letestu R, McIntyre E, Brouzes C.

Transfusion. 2007 Oct;47(10):1851-7.

PMID:
17880611
48.

Decreased transfusion needs associated with hydroxyurea therapy in Algerian patients with thalassemia major or intermedia.

Bradai M, Pissard S, Abad MT, Dechartres A, Ribeil JA, Landais P, de Montalembert M.

Transfusion. 2007 Oct;47(10):1830-6.

PMID:
17880608
49.

Hsp70 regulates erythropoiesis by preventing caspase-3-mediated cleavage of GATA-1.

Ribeil JA, Zermati Y, Vandekerckhove J, Cathelin S, Kersual J, Dussiot M, Coulon S, Moura IC, Zeuner A, Kirkegaard-Sørensen T, Varet B, Solary E, Garrido C, Hermine O.

Nature. 2007 Jan 4;445(7123):102-5. Epub 2006 Dec 10.

PMID:
17167422
50.

Overexpression of the heat-shock protein 70 is associated to imatinib resistance in chronic myeloid leukemia.

Pocaly M, Lagarde V, Etienne G, Ribeil JA, Claverol S, Bonneu M, Moreau-Gaudry F, Guyonnet-Duperat V, Hermine O, Melo JV, Dupouy M, Turcq B, Mahon FX, Pasquet JM.

Leukemia. 2007 Jan;21(1):93-101. Epub 2006 Nov 16.

PMID:
17109025

Supplemental Content

Loading ...
Support Center